Evidence map›Paper›PMID 39022063›Full record

ArticleHeliyon2024

Benzimidazole derivatives as a new scaffold of anticancer agents: Synthesis, optical properties, crystal structure and DFT calculations.

Mohamed Oussama Zouaghi, Donia Bensalah, Sabri Hassen, Youssef Arfaoui, Lamjed Mansour, Namık Özdemir, Hakan Bülbül, Nevin Gurbuz, Ismail Özdemir, Naceur Hamdi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mohamed Oussama ZouaghiLaboratory of Characterizations, Applications & Modeling of Materials (LR18ES08), Department of Chemistry, Faculty of Sciences of Tunis, University of Tunis El Manar, 2092, Tunisia.
Donia BensalahResearch Laboratory of Environmental Sciences and Technologies (LR16ES09), Higher Institute of Environmental Sciences and Technology, University of Carthage, Hammam-Lif, Tunisia.
Sabri HassenLaboratory of Characterizations, Applications & Modeling of Materials (LR18ES08), Department of Chemistry, Faculty of Sciences of Tunis, University of Tunis El Manar, 2092, Tunisia.
Youssef ArfaouiLaboratory of Characterizations, Applications & Modeling of Materials (LR18ES08), Department of Chemistry, Faculty of Sciences of Tunis, University of Tunis El Manar, 2092, Tunisia.
Lamjed MansourZoology Department, College of Science, King Saud University, Saudi Arabia, P.O. Box 2455, Riyadh, 11451, Saudi Arabia.
Namık ÖzdemirDepartment of Physics, Faculty of Science, Ondokuz Mayıs University, 55139, Samsun, Turkey.
Hakan BülbülDepartment of Physics, Faculty of Science, Ondokuz Mayıs University, 55139, Samsun, Turkey.
Nevin Gurbuzİnönü University, Faculty of Science and Art, Department of Chemistry, Malatya, 44280, Turkey.
Ismail Özdemirİnönü University, Faculty of Science and Art, Department of Chemistry, Malatya, 44280, Turkey.
Naceur HamdiResearch Laboratory of Environmental Sciences and Technologies (LR16ES09), Higher Institute of Environmental Sciences and Technology, University of Carthage, Hammam-Lif, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The absolute necessity to fight some class of tumour is perceived as serious health concerns, and the discovery and development of effective anticancer agents are urgently needed. So, the novel benzimidazole derivatives (

Indexed as

A8/nticancer evaluationBenzimidazole derivativesCytotoxicity assessmentDensity functional theory (DFT)UV absorption

Identifiers

PMID39022063
PMCPMC11252883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.